D
Dayi Hu
Researcher at Peking University
Publications - 3
Citations - 696
Dayi Hu is an academic researcher from Peking University. The author has contributed to research in topics: Acute coronary syndrome & TIMI. The author has an hindex of 3, co-authored 3 publications receiving 662 citations.
Papers
More filters
Journal ArticleDOI
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study
Martin Than,Louise Cullen,Louise Cullen,Christopher M. Reid,Swee Han Lim,Sally Aldous,Michael Ardagh,W. Frank Peacock,William A. Parsonage,Hiu Fai Ho,Hiu Fai Ko,Ravi R Kasliwal,Manish Bansal,Sunarya Soerianata,Dayi Hu,Rongjing Ding,Qi Hua,Kang Seok-Min,Piyamitr Sritara,Ratchanee Sae-Lee,Te Fa Chiu,Kuang Chau Tsai,Fang Yeh Chu,Wei Kung Chen,Wen Han Chang,Dylan Flaws,Peter M. George,A. Mark Richards +27 more
TL;DR: This novel ADP identifies patients at very low risk of a short-term major adverse cardiac event who might be suitable for early discharge and could be used to decrease the overall observation periods and admissions for chest pain.
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study
Martin Than,Louise Cullen,Louise Cullen,Christopher M. Reid,Swee Han Lim,Sally Aldous,Michael Ardagh,W. Frank Peacock,William A. Parsonage,Hiu Fai Ho,Hiu Fai Ko,Ravi R Kasliwal,Manish Bansal,Sunarya Soerianata,Dayi Hu,Rongjing Ding,Qi Hua,Kang Seok-Min,Piyamitr Sritara,Ratchanee Sae-Lee,Te Fa Chiu,Kuang Chau Tsai,Fang Yeh Chu,Wei Kung Chen,Wen Han Chang,Dylan Flaws,Peter M. George,A. Mark Richards +27 more
TL;DR: In this paper, a 2-h accelerated diagnostic protocol (ADP) was proposed to identify patients presenting with chest pain who have a low short-term risk of a major adverse cardiac event.
Journal ArticleDOI
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart,Jean-Luc Davignon,Michel P. Hermans,Khalid Al-Rubeaan,Pierre Amarenco,Gerd Assmann,Philip J. Barter,John Betteridge,Eric Bruckert,Ada Cuevas,Michel Farnier,Ele Ferrannini,Paola Fioretto,Jacques Genest,Henry N. Ginsberg,Antonio M. Gotto,Dayi Hu,Takashi Kadowaki,Tatsuhiko Kodama,Michel Krempf,Yuji Matsuzawa,Jesús Millán Núñez-Cortés,Carlos Calvo Monfil,Hisao Ogawa,Jorge Plutzky,Daniel J. Rader,Shaukat Sadikot,Raul D. Santos,Evgeny Shlyakhto,Piyamitr Sritara,Rody G. Sy,Alan R. Tall,Chee Eng Tan,Lale Tokgozoglu,Peter P. Toth,Paul Valensi,Christoph Wanner,Alberto Zambon,Junren Zhu,Paul Zimmet +39 more
TL;DR: Monitoring of non-HDL cholesterol provides a simple, practical tool for treatment decisions regarding the management of lipid-related residual cardiovascular risk, and several emerging treatments may offer promise.